… In this review, we focus on alterations in the metabolism of prostate cancer, including …
with metabolic reprogramming. Advances in our understanding of prostate cancer metabolism …

Prostate cancer (PCa) is the most common male malignancy and the fifth leading cause of
cancer death in men worldwide. Prostate cancer cells are characterized by a hybrid glycolytic/…

… prostate cancer cells. These results revealed that PTEN loss induced the metabolic
reprogramming of prostate cancer cells and promoted the malignant proliferation of prostate cancer …

New strategies are needed to predict and overcome metastatic progression and therapy
resistance in prostate cancer. One potential clinical target is the stem cell transcription factor …

… regarding systemic changes to fatty acid metabolism in PCa patients and how these …
peri-prostatic adipose tissue. We also analyzed cellular fatty acid metabolism in prostate cancer, …

… of this metabolic reprogramming. These clinical observations substantiate our findings
that elevated levels of SRC-2 promote prostate cancer metastasis by imparting metabolic …

… In this work, we have characterized the metabolic reprogramming of PC3 cells after etoposide
treatment, after which cells undergo three subsequent phases: degenerative, quiescent, …

… that metabolic reprogramming is a crucial feature of the highly aggressive tumor cells. In the
present work, we aim to utilize the metabolic … of the metabolic markers in CTCs detection. …

… central role in metabolic reprogramming for prostate cancer (PCa) growth and progression.
Mitochondria are metabolic powerhouses of the cell and support several hallmarks of cancer. …

… state-of-the-art metabolic imaging in identifying prognostic and predictive … metabolic
reprogramming in CR, and on the need for carefully designed clinical trials to evaluate metabolic …